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The original article \[[@CR1]\] contains three erroneous mentions of usage of a restriction enzyme---*Bst*Z17I---in the Methods section as displayed in the following sentences:\[...\] Therefore, *FOXO3* gene fragments (PCR products) had pcDNA3 sequences on the ends that corresponded to upstream and downstream sequences of the utilized restriction sites (*Dra*III for Arm1 and *Bst*Z17I for Arm2) in pcDNA3.\[...\] The intermediate vector (with *FOXO3* Arm 1) was cut with *Bst*Z17I, which is on the other side of the neomycin resistance gene in the pcDNA3 plasmid compared to *FOXO3* Arm 1.\[...\] *FOXO3* Arm 2 was amplified with the primer pair specified in Table 1, producing a product that had sequences on each end that were identical to the sequences proximal to the *Bst*Z17I site in the intermediate *FOXO3* Arm 1 vector.

As such, the above three sentences should instead have stated the correct restriction enzyme---*Bsm*I---in place of where *Bst*Z17I was mentioned in each instance.
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